Salvatore Sortino
Overview
Explore the profile of Salvatore Sortino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
612
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parisi C, Laneri F, Martins T, Fraix A, Sortino S
ACS Appl Mater Interfaces
. 2024 Oct;
16(44):59697-59720.
PMID: 39445390
The achievement of materials that are able to release therapeutic agents under the control of light stimuli to improve therapeutic efficacy is a significant challenge in health care. Nitric oxide...
2.
Laneri F, Parisi C, Natile M, Sortino S
J Mater Chem B
. 2024 Oct;
12(45):11817-11825.
PMID: 39435589
A nitric oxide (NO) photodonor (1) capable of releasing two NO molecules through a stepwise mechanism has been covalently grafted to blue-emitting N-doped carbon dots (NCDs). The resulting water-soluble nanoconjugate...
3.
Basile S, Parisi C, Bellia F, Zimbone S, Arrabito G, Gulli D, et al.
ACS Chem Neurosci
. 2024 Jul;
15(15):2916-2924.
PMID: 39036818
Several studies have highlighted the presence of nitration damage following neuroinflammation in Alzheimer's disease (AD). Accordingly, post-transcriptional modifications of β-amyloid (Aβ), including peptide nitration, have been explored as a marker...
4.
Parisi C, Laneri F, Fraix A, Sortino S
J Med Chem
. 2024 Jul;
67(19):16932-16950.
PMID: 39009572
The multifaceted role nitric oxide (NO) plays in human physiology and pathophysiology has opened new scenarios in biomedicine by exploiting this free radical as an unconventional therapeutic against important diseases....
5.
Martins T, Parisi C, Pinto J, Brambilla I, Melilli B, Aleo D, et al.
J Mater Chem B
. 2024 Jul;
12(31):7626-7634.
PMID: 39005154
The achievement of smart pharmaceuticals whose bioactivity can be spatiotemporally controlled by light stimuli is known as photopharmacology, an emerging area aimed at improving the therapeutic outcome and minimizing side...
6.
Martins T, Parisi C, Pinto J, Brambilla I, Malanga M, Ferreira-Strixino J, et al.
ACS Med Chem Lett
. 2024 Jun;
15(6):857-863.
PMID: 38894929
A hydrophobic nitric oxide (NO) photodonor integrating both nitroso and nitro functionalities within its chromophoric skeleton has been synthesized. Excitation of this compound with blue light triggers the release of...
7.
Laneri F, Parisi C, Seggio M, Fraix A, Longobardi G, Catanzano O, et al.
J Mater Chem B
. 2024 Jun;
12(26):6500-6508.
PMID: 38873736
The strict dependence of the biological effects of nitric oxide (NO) on its concentration and generation site requires this inorganic free radical to be delivered with precise spatiotemporal control. Light-activation...
8.
Parisi C, Pastore A, Stornaiuolo M, Sortino S
J Mater Chem B
. 2024 Apr;
12(21):5076-5084.
PMID: 38567488
Nitric oxide (NO) is a diatomic inorganic free radical ubiquitous in mammalian tissues and cells that plays a multifaceted role in a variety of physiological and pathophysiological processes. The strict...
9.
Laneri F, Seggio M, Parisi C, Beni S, Fraix A, Malanga M, et al.
ACS Appl Polym Mater
. 2023 Oct;
5(10):7918-7926.
PMID: 37854303
The achievement of biocompatible platforms for multimodal therapies is one of the major challenges in the burgeoning field of nanomedicine. Here, we report on a mixed β- and γ-cyclodextrin-based branched...
10.
Martins T, Parisi C, Suzuki Y, Hashimoto T, Nostro A, Ginestra G, et al.
Molecules
. 2023 Aug;
28(15).
PMID: 37570634
Developing biocompatible nitric oxide (NO) photoreleasing nanoconstucts is of great interest in view of the large variety of biological roles that NO plays and the unique advantage light offers in...